PubMed:33754144 / 893-1057 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/33754144","sourcedb":"PubMed","sourceid":"33754144","source_url":"https://www.ncbi.nlm.nih.gov/pubmed/33754144","text":"Patients were randomly assigned (1:1) centrally, with stratification by hospital site, to receive mavrilimumab 6 mg/kg as a single intravenous infusion, or placebo.","tracks":[{"project":"Inflammaging","denotations":[{"id":"T9","span":{"begin":0,"end":164},"obj":"Sentence"},{"id":"T9","span":{"begin":0,"end":164},"obj":"Sentence"}],"attributes":[{"subj":"T9","pred":"source","obj":"Inflammaging"},{"subj":"T9","pred":"source","obj":"Inflammaging"}]},{"project":"yangbin123xm_800_3","denotations":[{"id":"T5","span":{"begin":98,"end":110},"obj":"CI"},{"id":"T10","span":{"begin":156,"end":163},"obj":"CI"}],"attributes":[{"subj":"T5","pred":"source","obj":"yangbin123xm_800_3"},{"subj":"T10","pred":"source","obj":"yangbin123xm_800_3"}]},{"project":"chenxin_473849_800_3","denotations":[{"id":"T11","span":{"begin":156,"end":163},"obj":"CI"},{"id":"T6","span":{"begin":98,"end":110},"obj":"CI"}],"attributes":[{"subj":"T11","pred":"source","obj":"chenxin_473849_800_3"},{"subj":"T6","pred":"source","obj":"chenxin_473849_800_3"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"Inflammaging","color":"#93ecdc","default":true},{"id":"yangbin123xm_800_3","color":"#ecc293"},{"id":"chenxin_473849_800_3","color":"#a793ec"}]}]}}